Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4100+0.0300 (+0.68%)
At close: 04:00PM EST
Advertisement
Sign in to post a message.
  • W
    William
    Buyer and seller choices determine stock price, not companies. The fundamentals haven’t changed with Jasper. We will be fine
  • A
    Anonymous
    I like the promise of the approach of their flagship project, attempting to fully deplete bone marrow cells to improve hematopoietic stem cell transplants. The procedure used now is high dose chemotherapy, which comes with high toxicity and nasty side effects.
    But the problem with Jasper is the lead program is at too early a clinical stage to support the company having gone public. They are probably a couple of years away from having phase 2 safety and efficacy data in support of their flagship product, and as a consequence the market cap is going to remain in the low $hundred million for the foreseeable future.
    For me, this is a company to keep a close eye on for their scientific and clinical progress, but not one to invest in at such an early stage of corporate development.
  • k
    kornick
    If you’re looking for a short and sweet guide to the day’s biggest news, I recommend (http://trademarketview.tech). They breakdown the most important pre-market news and it only takes a few minutes to read.
  • W
    William
    Low volume causing this drop. All we need is some good news to make it pop. Be patient is all I can say. The whole market is down today so there’s nowhere to go
  • T
    Terminal Gravity
    Only a matter of time boys. This is going to be one of those stocks that catches some momo when small caps turn and I expect that to happen into year end and January.
    Bullish
  • W
    William
    The easiest way for a class action is to say too much, but this company says absolutely nothing. One of two reasons for this. Everything is bad or good news is coming. My only advice with this is to watch inside trading and remember this isn’t Abbott labs. It has one top product so what you get when it pops is an 80% jump and then it comes back to earth the next day. For me I’ll pass
  • J
    JC
    There is something seriously wrong/off with this company. It should have exploded up when it hit ~6.50. But the fact that it's trading so far below the 200MA during such an epic bull market says something is amiss in the first place. Something beyond the normal price fluctuations. Not trading like a valid company. Probably won't even be around a year or 2 from now. They just happened to show up on a high risk high reward screen. Still gotta do your due diligence. Somebody obviously knows more than the rest of us on this one. I for one, trust their expertise. Passing.
    Neutral
  • P
    Peter
    Are you Ready to ROCK the Stock Market?!? | www.StockRockandRoll.com
    Bullish
  • B
    Bert
    And I was thinking I did good when I bought at 9.40 couple of days ago. Oh boy, what a market.
  • T
    Terminal Gravity
    Accumulating a position. JSPR has all the makings of a biotech with big upside.
    Bullish
  • A
    All About Timing ⏱
    This garbage tricked us whe it went to $18 once we bought came to $8 a scam companies these days
  • W
    William
    JSPR hasn’t changed . It’s a steal at $8
  • B
    Bert
    Wow, I timed this one well. At least for now. But it sure is moving up big time now. Quiet board, but maybe not for long.:)
  • B
    Bert
    moving up nicely. Looks promising.
  • A
    Austin
    Ceo is dropping news tomorrow
    Bullish
  • B
    Bert
    Took some at 9.40. Hope I did the right thing. Sure looks like it wants to go to 10 bucks but not much volume. We'll see at the end of the day.
  • d
    debs
    why are we moving green against all the the red today?
  • A
    All About Timing ⏱
    Go to garbage I knew you guys will steal my money scammers up and once I bought you took it down CEO and his family members
  • C
    CIPTO
    I had feeling jspr will be $20 sooner
    Bullish
Advertisement
Advertisement